Kahlert H, Cromwell O, Fiebig H
Allergopharma Joachim Ganzer KG, R&D Department, Reinbek, Germany.
Clin Exp Allergy. 2003 Sep;33(9):1266-72. doi: 10.1046/j.1365-2222.2003.01756.x.
The assessment of the basophil-activating potential is an important aspect in the development of improved preparations for specific immunotherapy. The aim of the study was to evaluate the suitability of CD203c expression as a measure of basophil activation to compare allergoids with original allergen extracts, and recombinant hypoallergenic allergen derivatives with recombinant wild-type and natural allergens.
Heparinized whole blood samples from grass pollen allergic subjects were stimulated with grass pollen allergens and allergen derivatives followed by labelling of the basophils with PE-conjugated anti-CD203c. After lysis of the erythrocytes and fixation, the basophils were detected by flow cytometry. In some experiments, histamine release was determined simultaneously.
Grass pollen allergoids revealed a 10-10 000-fold reduction of basophil-activating capacity measured by CD203c expression. The deletion mutant DM4 of rPhl p 5b showed stronger hypoallergenic characteristics in a range of 50-10 000-fold reduction, whereas a combination mutant of rPhl p 5b and Phl p 6 revealed less hypoallergenic features. Histamine release experiments led to a similar outcome as CD203c measurement.
The measurement of CD203c expression on basophils by flow cytometry provides a rapid and sensitive method for the estimation of the allergic or hypoallergenic features of allergen preparations. The results demonstrated the hypoallergenicity of grass pollen allergoids and of the rPhl p 5b variant DM4, which may be a candidate in future preparations for specific immunotherapy.
嗜碱性粒细胞激活潜能的评估是改进特异性免疫治疗制剂研发中的一个重要方面。本研究的目的是评估CD203c表达作为嗜碱性粒细胞激活指标的适用性,以比较变应原疫苗与原始变应原提取物,以及重组低变应原性变应原衍生物与重组野生型和天然变应原。
用草花粉变应原和变应原衍生物刺激草花粉过敏受试者的肝素化全血样本,随后用PE偶联的抗CD203c标记嗜碱性粒细胞。红细胞裂解并固定后,通过流式细胞术检测嗜碱性粒细胞。在一些实验中,同时测定组胺释放。
通过CD203c表达测定,草花粉变应原疫苗显示嗜碱性粒细胞激活能力降低了10至10000倍。rPhl p 5b的缺失突变体DM4在50至10000倍的降低范围内表现出更强的低变应原性特征,而rPhl p 5b和Phl p 6的组合突变体显示出较弱的低变应原性特征。组胺释放实验结果与CD203c测量结果相似。
通过流式细胞术测量嗜碱性粒细胞上的CD203c表达,为评估变应原制剂的过敏或低变应原性特征提供了一种快速且灵敏的方法。结果证明了草花粉变应原疫苗和rPhl p 5b变体DM4的低变应原性,其可能是未来特异性免疫治疗制剂的一个候选物。